Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System-Reference-Cited by-同舟云学术

Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System

Published:2018-02-09 Issue:4 Volume:41 Page:403-413
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Golomb Beatrice A.,Verden Abril,Messner Alexis K.,Koslik Hayley J.,Hoffman Keith B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/article/10.1007/s40264-017-0620-4/fulltext.html

Reference89 articles.

1. Reinberg S. New guidelines may widen use of statins: recommendations focus on patient risk factors rather than cholesterol numbers, experts say. WebMD.com. 2013. http://www.webmd.com/cholesterol-management/news/20131112/heart-experts-warn-against-crash-diets . Accessed 30 Oct 2017.

2. Szabo L. New heart guidelines could put more Americans on statins. USA Today. 2013. http://www.usatoday.com/story/news/nation/2013/11/12/new-heart-guidelines-cholesterol-statins/3489491/ . Accessed 30 Oct 2017.

3. NICE publishes new draft guidelines on statin use. NHS Choices. 2014. http://www.nhs.uk/news/2014/02February/Pages/NICE-publishes-new-draft-guidelines-on-statins-use.aspx . Accessed 30 Oct 2017.

4. Hope J. One in four adults to be prescribed daily statins: now patients with 10% heart attack risk will be offered drug. Daily Mail. 2014. http://www.dailymail.co.uk/health/article-2557258/One-four-adults-prescribed-daily-statin-Now-patients-10-heart-attack-risk-offered-drug.html . Accessed 30 Oct 2017.

5. Cham S, Evans MA, Denenberg JO, Golomb BA. Statin-associated muscle-related adverse effects: a case series of 354 patients. Pharmacotherapy. 2010;30:541–53.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study;Acta Neurologica Belgica;2023-10-27

2. Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-09-09

3. Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications;Respiratory Medicine;2023-08

4. Virtual screening strategy for anti-DPP-IV natural flavonoid derivatives based on machine learning;Journal of Biomolecular Structure and Dynamics;2023-07-24

5. Mendelian Randomization Analysis Reveals Statins Potentially Increase Amyotrophic Lateral Sclerosis Risk Independent of Peripheral Cholesterol-Lowering Effects;Biomedicines;2023-05-04